Razan Mansour

MD| PGY-3 IM resident @KUMedCenter | Aspiring Hematologist/Oncologist | Clinical research/ Global Onc passionate | Mostly here to talk to myself🤷‍♀️

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Fantastic Medical Crossfire Meeting on Hematologic Malignancies @gotoPER #MXH26 in NYC July 2026, with great participation from our @Yale University @YaleCancer @YaleHematology group with 7 faculty & fellow participants. Mark your calendars for July 17-18, 2027 edition

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Glad to share our @Yale tour-de-force review of #MDSsm published in @Nature Reviews of Clinical Oncology (Free online read at https://t.co/GTWWl9intQ) which has to be the most comprehensive review we have ever written on the subject covering all relevant areas from epidemiology, pathogenesis, diagnosis, risk stratification, to current and evolving therapies for lower and higher risk disease @YaleCancer @YaleHematology @YaleMed

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Congratulations to an amazing new class of fellows @YaleCancer @YaleHematology @YaleHemOnc @Yale Looking forward to seeing all the great things you will do..

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Welcome to an outstanding group of heme/onc fellows joining @YaleCancer @YaleMed @YaleHematology @YaleHemOnc & a special welcome to dr Razan Mansour who is the first 🇯🇴 female fellow to join the combined Heme/Onc fellowship at @Yale following footsteps of @tariqkewan the first 🇯🇴 fellow, congratulations to all.

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

#ASH24 #mmsm @ASH_hematology

Nice algorithm for therapeutic anticoagulation for cancer associated VTE

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

#ASH24 @ASH_hematology #mmsm

Summary of recent immunotherapy in R/R MM with EMA and FDA approvals

[Razan Mansour @ramansour95]

@JOEBENNETTMD @Abdallah81MD @KortJeries @USMIRCNEWS @ASH_hematology @OncoAlert @KUcancercenter Thank you!! So excited!

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

We're so excited for our future Hematologist, @ramansour95, who is about to start her fellowship at Yale!

@KortJeries #mmsm #MedTwitter #USMIRC @USMIRCNEWS #ASH24 @ASH_hematology @OncoAlert @KUcancercenter

[Razan Mansour @ramansour95]

@Abdallah81MD @KortJeries @USMIRCNEWS @ASH_hematology @OncoAlert @KUcancercenter Thank you so much, Dr. Abdallah! Couldn’t have done it without your mentorship!!!

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🎉 Huge shoutout to our amazing mentees for your dedication during residency! Your hard work on research projects has led to matching for Heme-Onc Fellowship! We’re so proud of you, @ramansour95 @venkat28priya @DrAliyaRashid! Let’s celebrate! 🌟
#USMIRC @KUMedCenter @USMIRCNEWS @OncoAlert #MedTwitter

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

With my apologies to toddler parents everywhere…

“Don’t lose it, reuse it!”

Excellent @BloodAdvances work by Goel @MayoMyeloma @VincentRK @myelomaMD et al.

Re-using old myeloma #MMsm drugs can work, esp if years out.

Very relevant to post-CAR-T!

https://t.co/YFjLFZrdGI

[USMIRC News @USMIRCNEWS]

🧵 ASH abstracts via #USMIRC group (Myeloma subdivision): 3317 Optimal Treatment for Newly Diagnosed Primary Plasma Cell Leukemia: Multicenter Analysis
By @venkat28priya Barry Paul MD #mmsm #medtwitter #ASH2024
@KUcancercenter @LevineCancer
https://t.co/3eZEKCUTGY

[USMIRC News @USMIRCNEWS]

🧵 ASH abstracts via #USMIRC group (Myeloma subdivision) 1965 Comparative Efficacy of DPd Compared to DKd in Patients with RRMM Aged 70 and Above: A Multicenter Study. Present by @ramansour95 @KUcancercenter @hhashmi87 #MedTwitter #mmsm #ASH2024
https://t.co/DmlCL99HvO

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

DPd Vs DKd in RRMM in a retrospective study: https://t.co/fps202SO1S #mmsm #myeloma #MedTwitter #MedEd @OncoAlert @thisisJamesD @Rawana_97 @DimaDanai @NausheenAhmedMD #USMIRC #ASH23

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Daratumumab-Based Regimens in Anti-CD38 Treatment-Naïve Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics
OS in 2+ HRCyto RRMM 22.5 months! @j_snyder0132 @hhashmi87 @AimazAfrough @AtrashShebli @mumairmushtaq @NausheenAhmedMD #USMIRC #mmsm #myeloma #MedTwitter #MedEd #ASH23 @OncoAlert

https://t.co/DLVz6tk5C5

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Congratulations 🎉 to our #USMIRC group for getting 15 abstracts accepted @ASH_hematology and 7 online! Outstanding effort! Congratulations to the Mentors who assist all mentees during this journey and provide guidance 🙏 #MedTwitter #medEd #mmsm #myeloma @OncoAlert

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Congratulations 🎉🎊🎈 for our mentees and mentors #USMIRC group for getting their abstracts accepted @ASH_hematology 👏🏻👏🏻👏🏻 @KUcancercenter #mmsm #myeloma #MedTwitter #MedEd

[Ibrahim El Mikati @ibrahimelmikati]

Getting ready for KUMC Internal Medicine Research Day.
Posters Printing ✅️
@Reem_A_Mustafa @ramansour95 @KUMedCenter @KUJGKI @KUNeph @KUIMchiefs